Voriconazole Powder, For Suspension
Product Images NDC 59762-0935

16 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 59762-0935). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Voriconazole 01)

Chemical Structure (Voriconazole 01)
Chemical structure of voriconazole, showing its molecular arrangement including triazole and fluorinated phenyl groups.*
FDA Label Image

Logo (Voriconazole 02)

FDA Label Image

Logo (Voriconazole 02a)

FDA Label Image

Image (Voriconazole 04)

Image (Voriconazole 04)
An illustration showing components for dosing Voriconazole oral liquid, including a child-resistant bottle cap and bottle, a bottle adapter, and an oral dispenser comprising a plunger and tip.*
FDA Label Image

Image (Voriconazole 05)

Image (Voriconazole 05)
Illustration showing hands opening a child-resistant bottle cap by pushing down and twisting. The bottle appears to be a medication container, consistent with packaging for pharmaceuticals like Voriconazole 40 mg/mL by Mylan Pharmaceuticals Inc.*
FDA Label Image

Image (Voriconazole 06)

Image (Voriconazole 06)
An instructional illustration showing hands removing a cap from a bottle by pulling the cap upward. The bottle is held steady with one hand while the other hand grasps the cap. Two arrows indicate the directions for removing the cap.*
FDA Label Image

Image (Voriconazole 07)

Image (Voriconazole 07)
The image shows the top portion of a clear glass vial with a screw cap closure. The vial is partially filled with a liquid solution. No label or printed text is visible on the vial itself. It is consistent with a vial used for injectable pharmaceutical products like Voriconazole 40 mg/mL by Mylan Pharmaceuticals Inc.*
FDA Label Image

Image (Voriconazole 08)

Image (Voriconazole 08)
An instructional illustration showing hands holding and pressing a syringe attached to a vial, demonstrating how to draw liquid from the vial into the syringe by pulling the plunger downward. No text or labels are visible in the image.*
FDA Label Image

Image (Voriconazole 09)

Image (Voriconazole 09)
An instructional illustration showing a hand holding a syringe inserted into the opening of a bottle. The image demonstrates the process of drawing liquid medication from the bottle using the syringe, likely to prepare a dose for administration.*
FDA Label Image

Image (Voriconazole 10)

Image (Voriconazole 10)
An instructional illustration depicting a hand inserting a syringe into the rubber stopper of a vial, likely demonstrating the proper method to withdraw Voriconazole 40 mg/mL from its container.*
FDA Label Image

Image (Voriconazole 11)

Image (Voriconazole 11)
An instructional illustration showing a hand holding a bottle and another hand holding a syringe. The syringe is being inserted into the bottle, with an arrow indicating downward motion, likely illustrating how to draw liquid from the bottle.*
FDA Label Image

Image (Voriconazole 12)

Image (Voriconazole 12)
An instructional illustration showing a hand holding a syringe and drawing liquid medication from a bottle, demonstrating the proper technique for withdrawing a dose.*
FDA Label Image

Image (Voriconazole 13)

Image (Voriconazole 13)
An instructional drawing showing two hands holding a small vial. The top hand is positioned to twist or remove the vial cap, indicated with a circular arrow. This image likely illustrates how to open or handle the Voriconazole 40 mg/mL vial from Mylan Pharmaceuticals Inc.*
FDA Label Image

Logo (Voriconazole 14)

FDA Label Image

Principal Display Panel (40 mg Bottle Label)

Principal Display Panel (40 mg Bottle Label)
Label for Voriconazole oral suspension 40 mg/mL, a 75 mL reconstituted oral suspension, orange flavored. The product is a Greenstone brand distributed by Greenstone LLC, Peapack, NJ, and made in Ireland. The label provides storage instructions before and after reconstitution, mixing directions, and notes the suspension should be discarded 14 days after reconstitution.*
FDA Label Image

Principal Display Panel (40 mg Bottle Carton)

Principal Display Panel (40 mg Bottle Carton)
Voriconazole 40 mg/mL oral suspension carton label from Greenstone, a Mylan Pharmaceuticals Inc. brand. The label indicates an orange flavor and includes instructions for reconstitution and storage. It specifies the 75 mL bottle size when reconstituted. The packaging notes the product is for oral use only and includes an oral dispenser.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.